Search
for
Sort by
Research 601–630 of 1000+
- NANOEMULGEL AS A RECENT DRUG DELIVERY SYSTEM
- Bicalutamide: A potential new oral antiandrogenic drug for female pattern hair loss
- Association Between Gender and Drug Cost for Over-the-Counter Minoxidil
- Peptichemio: A New Oncolytic Drug in Combination with Vincristine and Prednisolone in the Treatment of Non-Hodgkin Lymphomas
- SUSPECTED CUTANEOUS DRUG TOXICITY IN RHEUMATOID ARTHRITIS—AN EVALUATION
- Advances in drug delivery systems based on liposome-composite hydrogel microspheres
- Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review
- Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease
- Exploring the Drug-Loading and Release Ability of FucoPol Hydrogel Membranes
- Hallelujah moments: tales of drug discovery
- Patents on Nanoparticulate Drug Delivery Systems - A Review
- Prevention of chemotherapy drug-mediated human hair follicle damage: combined use of cooling with antioxidant suppresses oxidative stress and prevents matrix keratinocyte cytotoxicity
- Formulation and evaluation of self-nanoemulsifying drug delivery system for improved oral delivery of exemestane hydrochloride
- Novel causes of drug-induced occupational asthma
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- Niosomes: A Novel Targeted Drug Delivery System
- DNN-DTIs: improved drug-target interactions prediction using XGBoost feature selection and deep neural network
- [Differences in efficacy between drug-eluting beads transbronchial arterial chemoembolization combined with systemic chemotherapy and systemic chemotherapy alone for unresectable lung squamous cell carcinoma].
- Entrepreneurship in Off-Label Drug Prescription: Just What the Doctor Ordered!
- The novel drug CS-891 inhibits 5alpha-reductase activity in freshly isolated dermal papilla of human hair follicles.
- [Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].
- The Effect of the Drug Minoxidil on Hair Growth
- Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol.
- A computer‐aided drug repurposing: the antibacterial agents targeting GroEL
- Data-driven strategies for drug repurposing: insights, recommendations, and case studies
- Ensuring safety in cytotoxic drug preparation: A systematic review of guidelines addressing education for pharmacy professionals
- Hair loss after drug reaction with eosinophilia and systemic symptoms (DRESS): A multicentric retrospective case series
- Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Severe Pustular Drug Eruptions From Amivantamab: A Case Series